Are Treatments More Effective than Placebos? A Systematic Review and Meta-Analysis

Abstract

BackgroundPlacebos are widely used in clinical practice in spite of ethical restrictions. Whether such use is justified depends in part on the relative benefit of placebos compared to ‘active’ treatments. A direct test for differences between placebo and ‘active’ treatment effects has not been conducted.ObjectivesWe aimed to test for differences between treatment and placebo effects within similar trial populations.Data SourcesA Cochrane Review compared placebos with no treatment in three-armed trials (no treatment, placebo, and treatment). We added an analysis of treatment and placebo differences within the same trials.Synthesis MethodsFor continuous outcomes we compared mean differences between placebo and no treatment with mean differences between treatment and placebo. For binary outcomes we compared the risk ratio for treatment benefit (versus placebo) with the risk ratio for placebo benefit (versus no treatment). We conducted several preplanned subgroup analyses: objective versus subjective outcomes, conditions tested in three or more trials, and trials with varying degrees of bias.ResultsIn trials with continuous outcomes (n = 115) we found no difference between treatment and placebo effects (MD = −0.29, 95% CI −0.62 to 0.05, P = 0.10). In trials with binary outcomes (n = 37) treatments were significantly more effective than placebos (RRR = 0.72, 95%CI = 0.61 to 0.86, P = 0.0003). Treatment and placebo effects were not different in 22 out of 28 predefined subgroup analyses. Of the six subgroups with differences treatments were more effective than placebos in five. However when all criteria for reducing bias were ruled out (continuous outcomes) placebos were more effective than treatments (MD = 1.59, 95% CI = 0.40 to 2.77, P = 0.009).Conclusions and ImplicationsPlacebos and treatments often have similar effect sizes. Placebos with comparatively powerful effects can benefit patients either alone or as part of a therapeutic regime, and trials involving such placebos must be adequately blinded.

Electroacupuncture and splinting versus splinting alone to treat carpal tunnel syndrome: a randomized controlled trial

“…From a pragmatic perspective, the nonspecific benefits of electroacupuncture characterized by patient-reported outcomes may be interpreted as clinical effect instead of bias. 48,49 Another limitation is that the generalizability of the results may be limited because this trial was performed at a single centre. Also, we acknowledge that higher needle numbers and more frequent sessions may have a positive correlation with effect size.…”

The Signaling Theory of Symptoms

“…The placebo effect has been known for a long time and has been replicated in many studies (Beecher, 1955;Howick et al, 2013). Originally, the term ''placebo effect'' or ''placebo response'' stood for an improvement of the patient's clinical state caused by a physiologically inert treatment (Benedetti, 2014).…”

Complete prevention and rapid sustained elimination of chemoradiation toxic mucositis, a case series with implications for mucositis pathobiology, cost of care, morbidity and premature cancer deaths

“…Rapid, complete and sustained reversal of a disease process at a rate that is 10 fold greater than otherwise expected is termed a positive Glasziou treatment effect [42] and qualifies HPPCLS as an effective therapeutic intervention. The difference in effect size between treatment and placebo is roughly 10-50 base points [43]. Therefore comparisons between placebo and any prospective intervention require control of biases that confound outcomes.…”